South Korea · Delayed Price · Currency is KRW CORESTEMCHEMON Statistics
Total Valuation
CORESTEMCHEMON has a market cap or net worth of KRW 129.31 billion. The enterprise value is 163.88 billion.
| Market Cap | 129.31B |
| Enterprise Value | 163.88B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CORESTEMCHEMON has 44.36 million shares outstanding. The number of shares has increased by 46.24% in one year.
| Current Share Class | 44.36M |
| Shares Outstanding | 44.36M |
| Shares Change (YoY) | +46.24% |
| Shares Change (QoQ) | +23.38% |
| Owned by Insiders (%) | 11.61% |
| Owned by Institutions (%) | 0.04% |
| Float | 39.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.03 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.12 |
| EV / Sales | 8.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.65 |
Financial Position
The company has a current ratio of 0.28, with a Debt / Equity ratio of 0.78.
| Current Ratio | 0.28 |
| Quick Ratio | 0.13 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.66 |
| Interest Coverage | -17.79 |
Financial Efficiency
Return on equity (ROE) is -66.14% and return on invested capital (ROIC) is -27.74%.
| Return on Equity (ROE) | -66.14% |
| Return on Assets (ROA) | -13.11% |
| Return on Invested Capital (ROIC) | -27.74% |
| Return on Capital Employed (ROCE) | -35.07% |
| Weighted Average Cost of Capital (WACC) | 10.16% |
| Revenue Per Employee | 510.75M |
| Profits Per Employee | -888.55M |
| Employee Count | 36 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 95.26 |
Taxes
In the past 12 months, CORESTEMCHEMON has paid 40.05 million in taxes.
| Income Tax | 40.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.42% in the last 52 weeks. The beta is 1.46, so CORESTEMCHEMON's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -6.42% |
| 50-Day Moving Average | 3,175.30 |
| 200-Day Moving Average | 2,413.81 |
| Relative Strength Index (RSI) | 41.90 |
| Average Volume (20 Days) | 1,283,060 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CORESTEMCHEMON had revenue of KRW 18.39 billion and -31.99 billion in losses. Loss per share was -901.46.
| Revenue | 18.39B |
| Gross Profit | -4.39B |
| Operating Income | -23.39B |
| Pretax Income | -31.95B |
| Net Income | -31.99B |
| EBITDA | -19.41B |
| EBIT | -23.39B |
| Loss Per Share | -901.46 |
Balance Sheet
The company has 2.88 billion in cash and 37.45 billion in debt, with a net cash position of -34.57 billion or -779.40 per share.
| Cash & Cash Equivalents | 2.88B |
| Total Debt | 37.45B |
| Net Cash | -34.57B |
| Net Cash Per Share | -779.40 |
| Equity (Book Value) | 48.15B |
| Book Value Per Share | 998.89 |
| Working Capital | -28.03B |
Cash Flow
In the last 12 months, operating cash flow was -11.93 billion and capital expenditures -2.14 billion, giving a free cash flow of -14.07 billion.
| Operating Cash Flow | -11.93B |
| Capital Expenditures | -2.14B |
| Depreciation & Amortization | 3.99B |
| Net Borrowing | -20.53B |
| Free Cash Flow | -14.07B |
| FCF Per Share | -317.18 |
Margins
Gross margin is -23.86%, with operating and profit margins of -127.21% and -173.97%.
| Gross Margin | -23.86% |
| Operating Margin | -127.21% |
| Pretax Margin | -173.75% |
| Profit Margin | -173.97% |
| EBITDA Margin | -105.54% |
| EBIT Margin | -127.21% |
| FCF Margin | n/a |
Dividends & Yields
CORESTEMCHEMON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.24% |
| Shareholder Yield | -46.24% |
| Earnings Yield | -24.74% |
| FCF Yield | -10.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CORESTEMCHEMON has an Altman Z-Score of -1.74 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.74 |
| Piotroski F-Score | 2 |